Market Place
Sourcing Support
EpiVax And CUBRC Awarded $2M FDA Contract For Control Peptides
24 Oct 2024 //
PR NEWSWIRE
EpiVax Licenses ISPRI Toolkit to Eisai for silico Immunogenicity Screening
20 Dec 2023 //
PR NEWSWIRE
EpiVax and Zoetis to Collaborate on Swine T cell Epitope Prediction Tool
10 Jan 2023 //
PR NEWSWIRE
GreenLight and Epivax Therapeutics Sign Exclusive Collaboration Agreement
09 Jan 2023 //
GLOBENEWSWIRE
EpiVax joins Intravacc, CEPI on project to develop betacoronavirus vaccine
31 Oct 2022 //
PHARMABIZ
EpiVax Secures Funding from FDA for Immunogenicity Risk Assessment
12 Sep 2022 //
PRNEWSWIRE
EpiVax Collaborates with Leidos on Malaria Vaccine Research
17 Nov 2021 //
PRNEWSWIRE
EpiVax Identifies T cell Epitopes critical to robust T cell immune in SARS-CoV-2
17 May 2021 //
PRNEWSWIRE
EpiVax and EpiVax Therapeutics Advance COVID-19 Vaccine Program, EPV-CoV-19
01 Jan 2021 //
BIOSPACE
EpiVax Advances "PANDA" Peptide Therapeutic Immunogenicity Screening Program
29 Dec 2020 //
PRNEWSWIRE
FDA Awards $1.1M Contract to CUBRC and EpiVax for Validation Immunoinformatic
22 Oct 2020 //
PRNEWSWIRE
FDA Awards $1.1M Contract to CUBRC and EpiVax for of New Immunoinformatic
21 Oct 2020 //
PRNEWSWIRE
EpiVax Announces Licensing of COVID-19 Vaccine Candidate to EpiVax Therapeutics
25 Aug 2020 //
PRNEWSWIRE
Intravacc and EpiVax to develop Covid-19 vaccine candidate
02 Jun 2020 //
PHARMACEUTICAL-TECHNOLOGY
Intravacc and EpiVax Team up in Development of COVID-19 Emerging Vaccine
02 Jun 2020 //
PRNEWSWIRE
Epivax and Entos Pharmaceuticals to develop DNA-based vaccine for COVID-19
29 Apr 2020 //
NEWS MEDICAL
Immunomic partners EpiVax and PharmaJet on Covid-19 vaccine
13 Apr 2020 //
PHARMACEUTICAL-TECHNOLOGY
Immunomic Therapeutics Forms Collaboration with EpiVax and PharmaJet
09 Apr 2020 //
YAHOO
EpiVax Partners with GAIA Vaccine Foundation to Make COVID-19 Vacc
07 Apr 2020 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.